Filter
1214
Text search:
viral
hepatitis
Featured
168
315
Language
Document type
605
290
120
62
56
29
25
10
5
4
1
1
1
Countries / Regions
58
40
36
25
25
23
22
21
21
21
21
20
20
17
16
16
16
15
13
12
12
11
11
11
11
10
9
9
8
8
8
7
7
6
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
468
156
42
42
39
22
19
1
Toolboxes
307
98
58
36
31
29
28
26
24
21
20
17
11
11
9
9
9
7
7
6
5
1
1
EACS produces Guidelines for the management of people living with HIV in Europe. The English version is regularly updated by the guidelines panels with major revision every other year and minor revisions in the years in between. Guidelines are published in the autumn and translated into additional l
...
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Public Health Situation Analysis and Interventions 10 October 2017
Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization
This manual provides practical guidelines for the management of children with severe malnutrition. It seeks to promote the best available therapy so as to reduce the risk of death, shorten the length of time spent in hospital, and facilitate rehabilitation and full recovery. Emphasis is given to the
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Evidence supports the need for a shift in the global approach to drug use. In this report, Do no harm: health, human rights and people who use drugs, UNAIDS shows what works to reduce the impact of HIV and other harms related to drug use. Countries that have moved away from laws and policies that ar
...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the
...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio
...
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
This section provides general information on HCW and key elements of management procedures that are essential to know before developing a HCWM plan.
